INB16 is the pharmaceutical grade cell line derived from CTV-1 and, although demonstrably different, their effects on resting NK cells are identical
North J, Bakhsh I, Marden C, Pittman H, Addison E, Navarrete C, Anderson R, Lowdell MW. Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence for a two-stage process in resting NK cell activation. Journal of Immunology; 178:85-94. PMID: 17182543
Sabry M, Lowdell MW. Tumour-primed NK cells; waiting for the green light. Frontiers in Immunology; 2013: 4:1-7. doi: 10.3389/fimmu.2013
Kottaridis PD, North, Tsirogianni M, Marden C, Samuel ER, Jide-Banwo S, Grace S, Lowdell MW. Two-stage priming of allogeneic Natural Killer cells for the treatment of patients with acute myeloid leukemia; a phase I trial. PLoS One; Jun 10;10(6):e0123416. doi: 10.1371
Natural killer cells differentiated in vitro from cord blood CD34+ cells are more advantageous for use as an immunotherapy than peripheral blood and cord blood natural killer cells.
Domogala A, Blundell M, Thrasher A, Lowdell MW, Madrigal JA, Saudemont A. Cytotherapy. 2017 Jun;19(6):710-720. doi: 10.1016/j.jcyt.2017.03.068. Epub 2017 Apr 17.
Biology Blood Marrow Transplant 2018:e-pub; https://doi.org/10.1016/j.bbmt.2018.06.019